Prognostic factors in advanced renal cell cancer

Camillo Porta, Ilaria Imarisio, Chiara Paglino, Elisa Ferraris, Mario Mensi, Bruno Rovereto

Research output: Contribution to journalArticlepeer-review


The identification of reliable and reproducible prognostic factors (defined as those factors that define the risk of death, or of recurrence, independently of therapy) in advanced renal cell carcinoma patients has became a priority in this field. To date, the Memorial Sloan Kettering Cancer Center - or Motzer's - criteria are those more commonly used, especially within clinical trials, but their role in the era of molecularly-targeted therapies is challenged. Molecular and genetic factors are currently being studied - with still conflicting results -, trying to incorporate them into presently available score systems and algorithms. The next generation of prognostic tools will probably include both genomic and proteomic techniques.

Original languageEnglish
Pages (from-to)35-37
Number of pages3
JournalEuropean Journal of Cancer, Supplement
Issue number14
Publication statusPublished - Oct 2008


  • Kidney cancer
  • Metastatic disease
  • Prognostic factors

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Prognostic factors in advanced renal cell cancer'. Together they form a unique fingerprint.

Cite this